Lab · The complete guide

Supplement Stability Shelf Life

TL;DR

Supplement stability and shelf-life testing is the manufacturer-owned program that supports any expiration date or 'best by' date on a dietary supplement label, and that justifies the overage built into the Master Manufacturing Record. Unlike drugs (which are bound to ICH Q1A protocol stability with FDA-approved expiry), supplements have no FDA-mandated stability protocol — but the moment a label bears an expiration date, the manufacturer is on the hook to demonstrate the product meets specification through that date, and FDA Warning Letters routinely cite the gap.

Reviewed May 25, 2026· By V5 Ultimate compliance team· 2,800 words · ~13 min read

01What supplement stability testing is

Supplement stability and shelf-life testing is a manufacturer-designed program that measures how a finished dietary supplement's identity, strength, purity, and composition change over time under defined storage conditions, in order to support a labelled expiration date (or 'best by' date, or 'best if used by' date — the labels carry different legal weight but the underlying obligation is identical). The program is the link between the at-release assay (the moment the finished-product specification is verified per 21 CFR 111.75(d) and the lot is QC-released) and the end-of-shelf-life assay (the moment a consumer might still be using the product). Without a stability program, the manufacturer has no scientifically-defensible basis for the expiration date printed on the label.

02Why it matters — the label-claim arithmetic

21 CFR 101.9(g) (cross-referenced by 101.36) requires that the assay of an added (Class I) nutrient be ≥100 % of label claim. The label claim is not 'at release' — it is at any point in the product's saleable life, up through the expiration date. So the at-release assay must be high enough that, after losses to thermal degradation, oxidation, hydrolysis, moisture, light, and container-closure interaction over the labelled shelf life, the end-of-shelf-life assay still lands ≥100 %. That mathematical gap is precisely what the overage in the MMR (21 CFR 111.210(e)) is designed to bridge — and the size of the overage cannot be set defensibly without stability data.

03What Part 111 actually says about stability

21 CFR Part 111 does NOT contain a stability subpart equivalent to the drug-cGMP §211.166. Stability obligations are distributed across several provisions:

111.70(e) requires the finished-product specification to address identity, purity, strength, composition, and contamination limits — implicitly through the labelled shelf life.
111.75(d) requires verification that the finished batch meets specs before release.
111.210(e) requires the MMR to specify the overage decided by QC to compensate for loss of activity 'during manufacture or expected shelf life of finished batch'.
111.260(j) requires the BPR to include any expiration date or shelf-life date assigned to the batch.
FDA 2007 Preamble (72 FR 34751) clarifies that the manufacturer 'must determine the dietary supplement meets specifications throughout its shelf life' if an expiration date is on the label.

The result: an expiration date on a supplement label is voluntary — but the moment it appears, the §403(a)(1) and §402(g) obligation attaches. Many supplement firms operationally treat 'best by' and 'expiration' as interchangeable; FDA does not, and a 'best by' date does NOT relieve the manufacturer of the stability evidence obligation if the label otherwise implies fitness for use through that date.

04Designing the stability protocol

Absent an FDA-prescribed protocol, the de facto industry standard derives from ICH Q1A(R2) (drugs) adapted to supplements, plus USP <1150> guidance:

Element	Typical supplement-stability practice
Storage condition — long-term	25°C / 60 % RH (Climate Zone II — temperate)
Storage condition — accelerated	40°C / 75 % RH for 6 months → supports tentative 24-month expiry pending long-term confirmation
Storage condition — intermediate (optional)	30°C / 65 % RH
Test intervals — long-term	0, 3, 6, 9, 12, 18, 24, 36 months (and beyond if claiming longer)
Test intervals — accelerated	0, 1, 2, 3, 6 months
Container-closure	Identical to commercial pack — bottle, induction seal, desiccant if used
Number of lots	Three primary lots representative of commercial process (manufactured at production scale where possible)
Statistical analysis	Linear regression of mean assay vs time; expiry = time at which lower 95 % confidence limit reaches 100 % of label claim

05What gets tested at each interval

A stability-indicating program tests the attributes most likely to drift over time. Typical panel for a dietary supplement:

Assay of labelled active(s) — vitamin C, B-complex, omega-3, probiotic CFU, botanical marker compound. Method must be stability-indicating (separates parent from degradants).
Physical attributes — appearance, friability/hardness (tablets), capsule integrity, disintegration time (USP <2040>).
Moisture content — Karl Fischer or LOD, particularly for hygroscopic actives.
Microbiological — TPC, yeast/mould, E. coli/Salmonella at intervals matching risk (water activity-driven).
Container-closure — bottle integrity, desiccant condition.
For probiotics specifically — viable CFU count by plate count or qPCR, at all intervals.
For omega-3 oils — peroxide value, anisidine value, oxidation stability (Rancimat or OXITEST).

06Actives most prone to potency loss — set overage accordingly

Active	Primary loss mechanism	Typical 24-month loss
Vitamin C (ascorbic acid)	Oxidation (moisture + oxygen + metal catalysis)	5–30 %
Vitamin A (retinyl palmitate)	Oxidation, light	10–25 %
Vitamin D3	Light, oxidation	5–15 %
Folate / folic acid	Light, oxidation	5–15 %
Thiamine (B1)	Hydrolysis, heat	5–15 %
Probiotics (viable CFU)	Moisture, heat, oxygen, time	30–80 % at 24 months without overage
Omega-3 (EPA/DHA)	Oxidation (rancidity)	Limited if antioxidant-protected
Curcumin	Light, alkaline pH	Low if formulated correctly
CoQ10	Light, heat	Low if encapsulated

The probiotic case is the most acute — overage of 100–200 % above label claim at the time of manufacture is common practice to ensure 1 billion CFU on the label still equates to 1 billion CFU at the consumer's mouth. Without a stability program quantifying the loss curve, the overage is a guess.

07Container-closure considerations

Stability data is container-specific. Re-packaging the same supplement into a different bottle, blister, or sachet starts a new stability obligation. Common container-closure variables:

Bottle resin (HDPE, PET) — oxygen transmission rate (OTR) and moisture vapour transmission rate (MVTR).
Bottle wall thickness — drives OTR/MVTR.
Cap liner — induction seal vs friction-fit; aluminium foil vs PE foam.
Desiccant — silica gel sachets or built-in canisters; size scaled to headspace volume.
Light protection — amber vs clear; opaque (HDPE) vs transparent (PET).
Headspace nitrogen flush — for highly oxidation-sensitive products (omega-3, vitamin C).

Switching from amber HDPE with desiccant + induction seal to clear PET without desiccant can cut shelf life in half. This is a Part 111 change-control trigger — the stability program must be re-established for the new container.

08Five 483 / Warning-Letter patterns

Expiration date on label with no stability data on file — automatic finding under 111.70(e).
Stability data on a different (smaller, lab-scale) batch size than the commercial batches — does not support the commercial shelf-life claim.
Stability data on a different container than the marketed one — supports the wrong shelf life.
Non-stability-indicating method (e.g. a UV assay that does not separate parent from degradants) — generates falsely-optimistic assay results.
Probiotic CFU claim with no viable-count stability data — most acute 483 pattern in the probiotic segment.

09How V5 Ultimate handles supplement stability

stability_protocols table keyed by (sku_id, revision), with conditions, intervals, attributes, container_closure_id, lots_under_study.
stability_pulls table — one per (lot_id × interval_month) — drives the LIMS test plan.
Linear regression + lower-95-% CL computed automatically; suggested expiry surfaces in /app/stability.
Label expiry date validated against approved stability data on label-artwork revision — block on mismatch.
Probiotic CFU stability supported as a first-class attribute with log10 regression option.
Container-closure change triggers an automatic stability re-establishment task.

Frequently asked questions

Q.Does Part 111 require a stability program?+

Not explicitly — Part 111 has no §211.166 analogue. But 111.70(e), 111.75(d), and 111.210(e) collectively require evidence that the product meets specification throughout the shelf life claimed on the label, which in practice can only be demonstrated by a stability program.

Q.Is 'best by' safer than 'expiration' for supplements?+

Operationally similar but legally distinct. 'Expiration date' implies fitness through the date; 'best by' implies optimal quality. FDA still expects evidence supporting whatever date appears on the label.

Q.Can I use accelerated stability (40°C/75% RH) to support a 24-month expiry?+

Tentatively. Six months at accelerated typically supports a tentative 24-month expiry, with long-term data at 25°C/60% RH confirming. The expiry should be re-evaluated once long-term data reaches the claimed shelf life.

Q.How many lots do I need to establish shelf life?+

Industry standard following ICH Q1A is three primary lots manufactured at commercial scale, in the marketed container-closure. Single-lot data is generally insufficient for a defensible expiry claim.

Q.Do I need to test EVERY active at EVERY interval?+

No — a bracketing and matrixing strategy is acceptable if scientifically justified. But the most-labile active in the product (typically vitamin C, folate, or a probiotic) sets the shelf life for the whole product.

Q.What happens to in-distribution product if a stability pull fails specification?+

Investigation, potential recall, and an immediate review of the overage and shelf-life claim. A failed stability pull is a deviation under 111.260 and may trigger a market action.

Q.Does the FDA approve the expiration date on a supplement?+

No — supplements have no premarket approval. The manufacturer is responsible for setting and supporting the expiry, and FDA enforces post-market through inspection and Warning Letters.